Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
49.50
+0.28 (0.58%)
At close: Oct 8, 2025, 4:00 PM EDT
49.50
0.00 (0.00%)
After-hours: Oct 8, 2025, 5:00 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $2.10 billion as of October 8, 2025. Its market cap has increased by 281.91% in one year.
Market Cap
2.10B
Enterprise Value
1.98B
1-Year Change
281.91%
Ranking
Category
Stock Price
$49.50
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $2.10B, an increase of 1,468.43%. That is a compound annual growth rate of 40.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 2.09B | 329.63% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.94B |
| Johnson & Johnson | 455.47B |
| AbbVie | 407.47B |
| UnitedHealth Group | 327.49B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.92B |